The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Seriously. A recent study on gender and drug recalls found that WebMD reviews from women were an early predictor of quality issues with drugs that later led to a product recall. When women have ...